UroGen Pharma (URGN) announced that the Centers for Medicare and Medicaid Services, CMS, has assigned a permanent Healthcare Common Procedure ...
ZUSDURI (mitomycin) for intravesical solution is a prescription medicine used to treat adults with a type of cancer of the lining of the bladder called low-grade intermediate risk non-muscle invasive ...
ZEVASKYN ® (prademagene zamikeracel) is an autologous cell sheet-based gene therapy indicated for the treatment of wounds in adult and pediatric patients with recessive dystrophic epidermolysis ...
Mesoblast Limited (NASDAQ:MESO) is one of the best hot stocks to invest in. On October 3, Mesoblast Limited announced that its product Ryoncil (remestemcel-L-rknd) was assigned a specific Healthcare ...
11d
Mesoblast (ASX:MSB) SecurES Permanent J-Code for Ryoncil—What Does This Mean for Broader Adoption?
Earlier this month, Mesoblast announced that its therapy Ryoncil received a permanent Healthcare Common Procedure Coding System (HCPCS) J-Code from the US Centers for Medicare and Medicaid Services, ...
DENVER--(BUSINESS WIRE)--TriSalus Life Sciences® Inc., (Nasdaq: TLSI), an oncology company integrating its novel delivery technology with immunotherapy to transform treatment for patients with liver ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback